Medication costs to private insurers of diversion of medications for attention-deficit hyperactivity disorder.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21473655)

Published in Pharmacoeconomics on July 01, 2011

Authors

Arnie P Aldridge1, Larry A Kroutil, Alexander J Cowell, Daniel B Reeves, David L Van Brunt

Author Affiliations

1: RTI International, Research Triangle Park, North Carolina 27709-2194, USA. aaldridge@rti.org

Articles by these authors

Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend (2006) 1.98

Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25. Addict Behav (2006) 1.88

Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res (2007) 1.87

Weight management using the internet a randomized controlled trial. Am J Prev Med (2008) 1.76

Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. Arch Gen Psychiatry (2010) 1.68

The nonmedical use of prescription ADHD medications: results from a national Internet panel. Subst Abuse Treat Prev Policy (2007) 1.64

Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents. J Adolesc Health (2006) 1.57

Associations of nonrestorative sleep with insomnia, depression, and daytime function. Sleep Med (2010) 1.48

A systematic review and meta-analysis of health care utilization outcomes in alcohol screening and brief intervention trials. Med Care (2011) 1.11

Molecular sensing with magnetic nanoparticles using magnetic spectroscopy of nanoparticle Brownian motion. Biosens Bioelectron (2013) 1.11

Simulations of magnetic nanoparticle Brownian motion. J Appl Phys (2012) 1.01

Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model. Health Econ (2011) 0.99

Effects of diversion on adults with co-occurring mental illness and substance use: outcomes from a national multi-site study. Behav Sci Law (2004) 0.99

Stimulant formulation and motivation for nonmedical use of prescription attention-deficit/hyperactivity disorder medications in a college-aged population. Am J Addict (2010) 0.93

Prevalence of nonmedical methamphetamine use in the United States. Subst Abuse Treat Prev Policy (2008) 0.91

The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone. J Clin Psychiatry (2006) 0.90

A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD). BMC Health Serv Res (2009) 0.88

Quantification of magnetic nanoparticles with low frequency magnetic fields: compensating for relaxation effects. Nanotechnology (2013) 0.86

Test-retest reliability of two patient-report measures for use in adults with ADHD. J Atten Disord (2010) 0.85

National estimates of behavioral health conditions and their treatment among adults newly insured under the ACA. Psychiatr Serv (2015) 0.84

Examining variation in treatment costs: a cost function for outpatient methadone treatment programs. Health Serv Res (2008) 0.83

Improvements in access to care for HIV and AIDS in a statewide Medicaid managed care system. Am J Manag Care (2003) 0.82

The effect of alternative staff time data collection methods on drug treatment service cost estimates. Eval Program Plann (2008) 0.82

A prospective study of the associations among housing status and costs of services in a homeless population. Psychiatr Serv (2014) 0.78

Impact of a statewide Medicaid managed care system on healthcare utilization and outcomes for people living with HIV. Am J Med Sci (2004) 0.78

Formal treatment, self-help, or no treatment for alcohol-use disorders? Evidence from the National Household Survey on Drug Abuse. J Stud Alcohol (2006) 0.78

Utilization of substance abuse treatment services under Medicare, 2001-2002. J Subst Abuse Treat (2008) 0.76

Decreased use of clonidine following treatment with atomoxetine in children with ADHD. J Clin Psychopharmacol (2006) 0.76

Course of major depressive disorder and labor market outcome disruption. J Ment Health Policy Econ (2010) 0.75

Datapoints: racial and ethnic patterns in claim-identified mental disorders among disabled medicare beneficiaries. Psychiatr Serv (2009) 0.75

The cost of implementing a jail diversion program for people with mental illness in San Antonio, Texas. Eval Program Plann (2015) 0.75